Open Predictor Clinical Intelligence
OPCI is a MedTech company that collaborates with healthcare professionals to develop clinical intelligence software, specifically OpenPredictor, which predicts patients' risk of post-operative complications. Founded by NHS surgeons, OPCI aims to enhance patient care and streamline pre-operative pathways through innovative technology. Their solutions are designed to improve surgical outcomes and optimize healthcare delivery, making them a valuable partner for healthcare organizations.
Open Predictor Clinical Intelligence
OPCI is a MedTech company that collaborates with healthcare professionals to develop clinical intelligence software, specifically OpenPredictor, which predicts patients' risk of post-operative complications. Founded by NHS surgeons, OPCI aims to enhance patient care and streamline pre-operative pathways through innovative technology. Their solutions are designed to improve surgical outcomes and optimize healthcare delivery, making them a valuable partner for healthcare organizations.
TL;DR
Product: OpenPredictor — an AI/ML clinical decision aid that predicts risk of post‑operative complications for elective surgery
Founders: Justin Green (Founding Director & CEO) and Mike Reed (Founder & Chairman; Professor) — both described as NHS surgeons
Headquarters: Newcastle Upon Tyne, United Kingdom
Funding signals: Recorded Pre‑Seed activity (Jul 2024) and a non‑equity assistance round with the Association of British Healthcare Industries listed as lead
Company Overview
Problem Domain
Pre‑operative assessment and risk prediction for elective surgery
Industry
MedTech
Funding Track Record
Pre‑Seed round announced Jul 1, 2024 and closed Aug 31, 2024; pre‑money valuation listed as £2.3M.
Listed as lead investor for a non‑equity assistance round; amounts and specific dates are not disclosed in the accessible records.
Investor Signal
“Association of British Healthcare Industries listed as lead investor for a non‑equity assistance round”